
In updated guidance issued Thursday, the World Health Organization now recommends against using the antibody drugs sotrovimab and casirivimab-imdevimab for patients with COVID-19. This recommendation replaces previous conditional recommendation for these antibody drugs. The change in guidance was based on emerging evidence that the medications — which work by binding to the SARS-CoV-2 spike protein,… read on > read on >